Full-Year Profit Soars 39% to RMB318 Million
Beauty Farm Medical and Health Industry (02373.HK) announced a strong financial performance for the year ending December 2025. The company's net profit increased 39% year-over-year to RMB318 million, while annual revenue climbed 16.7% to RMB3.001 billion. This robust growth translated to earnings per share of RMB1.38, reflecting operational strength and effective management.
Dividend Jumps 38.5% in Competitive Market
Reflecting its positive results, the company raised its final dividend to HKD0.72 per share, a significant 38.5% increase from the HKD0.52 declared in the previous year. This move to enhance shareholder returns comes as China's medical aesthetic industry undergoes structural adjustments, with consumers becoming more value-driven. The dividend hike signals management's confidence in sustained cash flow and profitability, even as competitors like So-Young aggressively expand their market footprint.
Firms Race for Scale in Value-Driven Market
The strong results from Beauty Farm arrive as the broader Chinese medical aesthetics market consolidates. Competitor So-Young reported that its aesthetic center business revenue grew over 205% year-over-year in Q4 2025, driven by a rapid expansion to 49 locations. So-Young plans to open at least 35 new centers in 2026, aiming to build China's largest medical aesthetic chain. This race for scale highlights a market shift where companies are competing on both service quality and network size to capture a consumer base that is increasingly focused on value and trusted brands.